The largest database of trusted experimental protocols

Propofol

Manufactured by Fresenius
Sourced in Germany, Austria, China, United States, United Kingdom, Belgium, Sweden, Israel

Propofol is a pharmaceutical product used as a general anesthetic and sedative. It is a sterile, nonpyrogenic injectable emulsion that contains the active ingredient propofol and other inactive ingredients. Propofol is administered intravenously and is used to induce and maintain general anesthesia, as well as for sedation in intensive care unit (ICU) settings.

Automatically generated - may contain errors

93 protocols using propofol

1

Pediatric General Anesthesia Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
No children were pre-medicated. Children routinely fasted from food for ≥6 h and from drink for ≥4 h before surgery. Peripheral intravenous access was established for all patients in the hospital ward. In the operating room, a continuous monitor (S/5TM monitor; GE Healthcare, Germany) was used for noninvasive blood pressure (NIBP), pulse oxygen saturation (SpO2), heart rate (HR), and electrocardiogram (ECG) monitoring. After oxygen inhalation via a facemask was initiated, general anesthesia was induced by the continuous intravenous injection of 3 mg/kg of propofol (1% propofol in a medium-chain/long-chain triglyceride emulsion; Fresenius Kabi Deutschland Gmbh, Germany) for over 30 s, followed by an observation period of 4 min. Routine oxygen inhalation via the facemask was continued during propofol administration, and the lower jaw was gently raised as needed to assist airway management and maintain a blood oxygen saturation of ≥97%. At the end of the observation period, 2 mg/kg of propofol (Fresenius Kabi Deutschland Gmbh, Germany), 2 μg/kg of fentanyl (Yichang Humanwell Pharmaceutical Co., Ltd., Hubei Province, China), and 0.5 mg/kg of rocuronium (Hameln Pharmaceuticals Gmbh, Germany) were administered for routine induction. The patient was intubated or received a laryngeal mask after a sufficient depth of anesthesia was achieved.
+ Open protocol
+ Expand
2

Propofol for Endotracheal Intubation Readiness

Check if the same lab product or an alternative is used in the 5 most similar protocols
Propofol was used as standard of care for endotracheal intubation in our units. Propofol (Fresenius Kabi, Schelle, Belgium) was administered as intravenous bolus followed by a saline flush for a total duration of 30 s. After Propofol administration, the pre-intubation sedation level was assessed every 30 s up to 3 min after the infusion, using the Intubation Readiness Score (IRS).22 (link) When the pre-intubation sedation level was adequate, intubation was continued. In the case of insufficient pre-intubation sedation level after 3 min, additional Propofol was administered until the pre-intubation sedation level was sufficient. The amount of each additional Propofol dose was left at the discretion of the attending physician. After intubation, the quality of intubation was measured by the Viby-Mogensen intubation score.23 (link) Data regarding Propofol doses and intubation attempts were reported.
+ Open protocol
+ Expand
3

Anesthesia Protocol for Large Animal Transplant

Check if the same lab product or an alternative is used in the 5 most similar protocols
The animals were premedicated with 0.5 mg/kg of diazepam and 5 mg/kg of ketamine hydrochloride intramuscularly, followed by general anesthesia using 1 mg/kg of propofol (Fresenius Kabi, Bad Homburg, Germany) intravenously (i.v.), and maintained with a mix solution of 0.25 mg/kg/h of diazepam, 2.5 mg/kg of ketamine hydrochloride, and 0.0125 mL/kg/h of compound detomidine hydrochloride or 0.5 mg/kg/h of propofol i.v. in turn. The respiration was supported by a ventilator (Dräger, Lübeck, Germany) through an inserted trachea cannula. Five hundred milliliters of 5% glucose and 0.9% sodium chloride and 500 mL of hydroxyethyl starch 130/0.4 and sodium chloride injection (Fresenius Kabi, Bad Homburg, Germany) were also administered i.v.. In addition, 100 mL of 0.3 g of levofloxacin lactate and 2 million units of benzylpenicillin were given i.v. 30 min before surgery. The same anesthetic protocol was used for donor retrieving and transplantation.
+ Open protocol
+ Expand
4

General Anesthesia Protocol for Small Animal

Check if the same lab product or an alternative is used in the 5 most similar protocols
After premedication with atropine (0.01 mg/kg) and midazolam (0.1 mg/kg), anesthesia was induced by bolus dose of propofol (1% Fresenius Kabi) from 2.5 to 3.5 mg/kg body weight, and after was maintained by continuous infusion of propofol using infusion pump (3–15 mg/kg/h). For analgesia, fentanyl was administered at a dose of 1–2 mcg/kg during the induction, and, if needed, it was added at the dose of 0.5 to 1 mcg/kg during anesthesia. Muscle relaxation was provided by rocuronium bromide in a bolus dose of 0.6–1 mg/kg, followed by 0.2 to 0.3 mg/kg every 20 mins. Atropine 0.02 mg/kg and prostigmine 0.05 mg/kg were given for the reversal of the neuromuscular block. Patients are ventilated by oxygen and air (35: 65%; 50: 50%) or oxygen and nitrous oxide (35: 65%). During anesthesia, vital parameters were monitored (systolic and diastolic pressure, heart rate, oxygen saturation, end-tidal carbon dioxide), and, in individual patients, the depth of sedation and anesthesia was measured by analyzing the value of the bispectral index (BIS).
+ Open protocol
+ Expand
5

Propofol's Effect on Liver Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Lgr5+ cells were isolated from biopsies from livers of two healthy donors as previously described.25 Use for our studies was approved by the Medical Ethical Committee of our hospital (STEM study). Liver stem cell organoids were passaged to fresh matrigel and cultured in expansion medium (EM) for 3 days, after which differentiation towards hepatocyte‐like cell was started by replacement of EM for differentiation medium (DM). DM was refreshed every 2 to 3 days and after 5 days, propofol (Fresenius) was added in a concentration of 0, 100, 300, or 900 μM. After 24 hours of incubation with propofol, organoids were harvested for messenger RNA (mRNA) analysis.
+ Open protocol
+ Expand
6

Propofol Exposure on Liver Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Lgr5+ cells were isolated from biopsies from livers of two healthy donors as previously described (25 (link)). Use for our studies was approved by the Medical Ethical Committee of our hospital (STEM study). Liver stem cell organoids were passaged to fresh matrigel and cultured in expansion medium (EM) for three days, after which differentiation towards hepatocyte-like cell was started by replacement of EM for differentiation medium (DM). DM was refreshed every 2–3 days and after 5 days, propofol (Fresenius) was added in a concentration of 0, 100, 300 or 900 μM. After 24 hours of incubation with propofol, organoids were harvested for messenger RNA (mRNA) analysis.
+ Open protocol
+ Expand
7

Propofol Exposure in Hippocampal Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
Propofol was purchased from Fresenius Kabi Austria GmbH (Graz, Austria). As previously described (29 (link),30 ), the hippocampal neurons were exposed to 50 µmol/l Propofol for 0, 6, 12 and 24 h. Subsequently, cells were transfected with 50 nM PEA15 cloned in pcDNA3.1 or empty pcDNA3.1 vectors (Invitrogen; Thermo Fisher Scientific, Inc.) using Lipofectamine® 2000 (Thermo Fisher Scientific, Inc.) and cultured for 48 h at 37°C. A total of six experimental groups were considered in the present study: Control group (0.1% PBS), empty-vector group (transfected with pcDNA3.1 vector), PEA15 group (transfected with PEA15), Propofol group (treated with 50 µmol/l Propofol), empty-vector + Propofol group (transfected with pcDNA3.1 empty vector and treated with 50 µmol/l Propofol), and PEA15+Propofol group (transfected with PEA15 and treated with 50 µmol/l Propofol).
+ Open protocol
+ Expand
8

Anesthesia Protocol for Canine Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dogs were sedated with 30 μg/kg atropine (atropine sulfate; Mitsubishi Tanabe Pharma Co., Osaka, Japan), 0.15–0.2 mg/kg butorphanol (Betorufaru; Meiji Seika Pharma Co, Ltd., Osaka, Japan) and 0.2 mg/kg atropine and 0.1–0.15 mg/kg midazolam (Dormicum, Astellas Pharma, Tokyo, Japan) were administered intravenously. Anesthesia was induced with 6 mg/kg propofol (Fresenius Kabi, Tokyo, Japan), followed by tracheal intubation. Maintenance of anesthesia was achieved with isoflurane (Isoflu; DS Pharma Animal Health, Osaka, Japan) and oxygen. The oxygen was administered at a flow rate of 1–2 L/min, and the minimum alveolar concentration of isoflurane was regulated between 1.5 and 2.0.
+ Open protocol
+ Expand
9

Propofol and TRPV4 Modulation in Cardioprotection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The propofol we used on isolated mice hearts (10 mg/ml, Fresenius Kabi GmbH, Graz, Austria) was dissolved in an intralipid suspension including soybean oil (10%), egg phosphatide (1.2%), and glycerol (2.25%). An equivalent volume of intralipid (INTRA, 20%, Sigma Aldrich, St. Louis, MO, USA) was used as a vehicle control. In cell experiments, we applied pure propofol monomers (TCI Shanghai, Shanghai, China), which were dissolved in dimethyl sulfoxide (DMSO). propofol dosage (25, 50, 100 μM ex vivo; 12.5, 25, 50, 100 μM in vitro) was based on the volume previous studies applied (Xia et al., 2006 (link); Sun et al., 2017 (link)). TRPV4 agonists GSK1016790A (20 nM ex vivo and 300 nM in vitro) and 4α-PDD (3 μΜ in vitro) and TRPV4 antagonist HC-067047 (0.1 μM ex vivo and 1 μM in vitro) were all from Sigma Aldrich and were dissolved in DMSO. The percentage of DMSO in the final solution was less than 0.01%.
+ Open protocol
+ Expand
10

Anesthesia and Neuromonitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were briefly anesthetized with a mixture of medical oxygen and isoflurane (5% induction, 2.5% maintenance) for the placement of a lateral tail vein catheter preloaded with heparinized saline (50 U.I./mL), followed by the continuous infusion of propofol (40 ± 2 mg/kg/hour; Fresenius Kabi, The Netherlands). propofol anesthesia was used during MEP recordings, because at low propofol doses, stable MEP responses can be measured over a period of four hours 20.
Isoflurane was maintained at 2.5% during the first 5 min of propofol infusion, where after isoflurane delivery was discontinued. A 20‐min washout period of isoflurane was endorsed, before the onset of MEP measurements, to limit the suppressive effect of isoflurane on MEPs 21, 22. Meanwhile, the rat's head was shaved (to ensure close contact of the TMS coil with the skull) and the animal was fixed in a stereotaxic frame. During the entire experimental procedure, the body temperature of the animals were maintained at 37°C using a rectal temperature feedback probe connected to a circulating water‐heated pad system.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!